Pixium Vision (PXMVF) News Today → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free PXMVF Stock Alerts C$1.50 0.00 (0.00%) (As of 04/30/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesStock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineScience Corporation acquires retinal implant from Pixium Visionmsn.com - April 26 at 3:33 PMWhen Is Apple Vision Pro Coming Out in the UK and Elsewhere?macrumors.com - March 27 at 12:54 PMPixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conversion of the receivership proceedings into liquidation proceedingsfinance.yahoo.com - February 2 at 10:37 AMPostponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024finance.yahoo.com - January 17 at 2:00 PMPostponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedingsfinance.yahoo.com - January 17 at 9:00 AMDecision concerning the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings scheduled for January 16, 2024finance.yahoo.com - December 18 at 5:51 PMCommercial Court hearing to examine the takeover offer scheduled for December 18, 2023finance.yahoo.com - December 4 at 6:13 AMUpdate on the receivership proceedings: submission of a takeover offer to the court-appointed administratorsfinance.yahoo.com - November 20 at 1:56 PMPixium Vision announces the 48-Month Trial Results in Severe Atrophic AMDfinance.yahoo.com - November 14 at 1:41 AMPixium Vision announces the conversion of the safeguard proceedings into receivershipfinance.yahoo.com - November 13 at 3:41 PMPixium Vision SA Ordinary Sharesmorningstar.com - November 4 at 10:16 AMPixium Vision SA GAAP EPS of -€0.07, revenue of €0.9Mmsn.com - October 26 at 2:00 PMPixium Vision announces its financial results for H1 2023 and provides updatefinance.yahoo.com - October 26 at 8:59 AMPixium Vision announces the launch of a process to find buyersbenzinga.com - October 18 at 6:29 PMPixium Vision announces the opening of safeguard proceedingsbenzinga.com - October 9 at 2:15 PMPixium Vision announces the completion of the reverse stock split of its shares on the basis of 1 new share for 50 existing shares and the start of trading of the shares resulting after the completion of the reverse split as of Sep 21, 2023finance.yahoo.com - September 20 at 12:33 PMPixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the basis of 1 new share for 50 existing sharesfinance.yahoo.com - July 28 at 9:18 PMPixium Vision announces the agreement to extend the maturity date of the outstanding notes associated with the terminated ESGO financing facilityfinance.yahoo.com - July 11 at 8:33 AMResults of the Annual General Shareholder Meeting as of June 13, 2023finance.yahoo.com - June 15 at 9:51 AMPixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Creditfinance.yahoo.com - June 12 at 1:23 PMBefore 'car chase,' Duchess Meghan spoke about fighting for equity at Women of Vision galausatoday.com - June 9 at 1:16 PMPixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Creditfinance.yahoo.com - June 8 at 4:11 AMAnnual Meeting of Shareholders June 13, 2023 / Availability of preparatory documentsfinance.yahoo.com - May 24 at 2:09 PMPixium Vision S.A.wsj.com - May 23 at 8:12 PMPixium Vision convenes its Annual Meeting of Shareholders on June 13, 2023finance.yahoo.com - May 10 at 4:54 PMPixium Vision announces the availability of its annual report for the financial year 2022finance.yahoo.com - April 25 at 3:16 PMPixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023finance.yahoo.com - April 21 at 2:09 AMCommunication following the announcement of FDA Breakthrough Device Designation for the Prima System in Dry AMDfinance.yahoo.com - April 3 at 1:36 AMPixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMDfinance.yahoo.com - March 31 at 1:06 AMReduction of share capital due to losses by reduction of nominal value: number of shares unchangedfinance.yahoo.com - March 17 at 8:29 AMResults of Extraordinary Shareholders Meeting held on March 8, 2023finance.yahoo.com - March 10 at 5:52 PMExtraordinary Shareholder Meeting of March 8, 2023: Notice of publication of the preparatory documentsfinance.yahoo.com - February 28 at 1:41 PMSecond convening of the Extraordinary Shareholder Meeting on March 8, 2023finance.yahoo.com - February 16 at 3:01 PMPixium Vision announces its cash position at 31 December 2022 and provides an update on its activitiesfinance.yahoo.com - February 14 at 7:58 PMPixium Vision announces termination of convertible note financing agreement with US-based healthcare investor ESGOfinance.yahoo.com - February 13 at 6:05 PMExtraordinary General Meeting of February 15, 2023: Notice of publication of the preparatory documentsfinance.yahoo.com - January 27 at 3:37 PMPixium Vision convenes an Extraordinary General Meeting of Shareholders on February 15, 2023finance.yahoo.com - January 20 at 5:24 PMPixium Vision announces peer-reviewed publications demonstrating the potential of the Next Generation PRIMA implant to restore vision at five times higher resolution than current implantfinance.yahoo.com - January 12 at 1:31 AMPixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023 and regulatory submission in Europe in H1 2024finance.yahoo.com - December 15 at 7:50 AMPixium Vision announces participation in investor conferences in November and December 2022finance.yahoo.com - November 15 at 10:40 AMPixium Vision SA (ALPIX)investing.com - November 6 at 3:53 AMPixium Vision announces its cash position at 30 September 2022 and provides an update on its activitiesfinance.yahoo.com - October 21 at 3:33 AMPixium Vision announces the publication of peer-reviewed clinical data of the Prima System in Dry AMD in the Journal of Neural Engineeringfinance.yahoo.com - October 11 at 10:49 AMPixium Vision announces participation in investor conferences and events in October 2022finance.yahoo.com - October 4 at 8:19 AMPixium Vision to host open house event for investors on October 13th 2022 from 5 pmfinance.yahoo.com - September 21 at 2:53 AMPixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022finance.yahoo.com - September 19 at 4:43 AMPixium Vision announces implantation of first patient in Italy in Prima System European pivotal trial PRIMAverafinance.yahoo.com - September 13 at 2:01 AMPixium Vision announces participation in upcoming investor conferences in September 2022finance.yahoo.com - September 6 at 6:00 AMPixium Vision announces participation in upcoming scientific conferences in September 2022finance.yahoo.com - August 29 at 4:20 AMPixium Vision to attend H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference on August 17, 2022finance.yahoo.com - August 11 at 5:51 PM Get Pixium Vision News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMVF and its competitors with MarketBeat's FREE daily newsletter. Email Address Truth about Trump you’ve never heard (Ad)Everything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump. For the full story, click here. PXMVF Media Mentions By Week PXMVF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PXMVF News Sentiment▼0.000.34▲Average Medical News Sentiment PXMVF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PXMVF Articles This Week▼10▲PXMVF Articles Average Week Get Pixium Vision News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMVF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ansell News Carl Zeiss Meditec News Coloplast A/S News ConvaTec Group News Fisher & Paykel Healthcare News Gerresheimer News InnerScope Hearing Technologies News Innovative Eyewear News Nanosonics News Olympus News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PXMVF) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersThe Gold Grab of the CenturyColonial MetalsProtect Your Bank Account Before It’s Too LateWeiss RatingsTrump’s last act as President Porter & CompanyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsIs Tesla going out of business?DTIElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceREAD THIS – If You Missed Out On The AI BoomBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pixium Vision SA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
